Healthcare Trends & Insights

The team at MWV Healthcare monitors and studies the complex and dynamic healthcare industry to keep our customers informed. In this space, we'll regularly share the insights of MWV Healthcare experts on a wide range of issues from adherence to regulation to child resistance. If anything strikes you as interesting or helpful, we encourage you to subscribe, share with colleagues, and as always, contact us if you're interested in learning more.


  • Child-resistant (CR) medication packaging is one of the best-documented successes in preventing the unintentional poisoning of children[i].  Since the United States Poison Prevention Act was passed in 1970, the use of CR packaging has prevented thousands of poisonings and saved many children’s lives. [ii]

    Regulations for CR packaging differ around the world. But the responsibility to consider CR packaging for medication goes beyond simply meeting regulations. If medication toxicity

    more...
    Hung Le, Vice President, Innovation Engagement, MWV
  • At the inaugural EyeForPharma Patient-Centered Clinical Trials event this September, MWV’s Chief Science Officer will present a discussion of data about “Electronic Measurement of Patient Adherence in Clinical Trials – Getting Patients Off to a Good Start.”

    Interested in a preview? MWV has contributed an article on this topic to the EyeForPharma blog, Management of Patient Adherence in Clinical Trials Using Electronic Monitoring.

    When registering for the event, use the

    more...
  • The market for over-the-counter (OTC) medications is growing as more and more prescription medications make the switch. The “Rx-to-OTC switch” market is expected to reach $15B in the United States by 2015[i], with eight of the current top 20 OTC brands in Europe being the result of product switches[ii]. A recent report has identified $30B worth of potential Rx-to-OTC switches in a wide range of indications, from hypertension and COPD to high cholesterol[iii]

    more...
  • Improving medication use and adherence is a system-wide challenge. With approximately 50 percent of patients not taking their medications as prescribed across disease states and health conditions, moving the needle even a little toward better adherence can make a big difference.

    more...
  • In order to effectively address the challenge of patient medication non-adherence, two requirements must be met: enhanced patient engagement in the intervening process and collaboration among those providing patient care and supporting programs. This is the focus of the upcoming 2nd Annual World Congress Summit to Improve Adherence and Increase Patient Engagement.

    more...
  • Baby boomers are turning 65 at the rate of 10,000 per day. This trend will place strain on our nation’s overwhelmed health care system as well as the associated growing number of caregivers.  The resulting impact will be seen in both expected and unexpected ways.

    There are a growing number of people who are now responsible for taking care of family members or loved ones with age-related chronic conditions.

    more...
  • Patient medication non-adherence is primarily driven by behavioral reasons, such as simple procrastination or forgetfulness (69 percent), an Express Scripts study uncovered. In order to improve adherence, we must find solutions that change behavior. Habits are an important aspect of human behavior, writes Charles Duhigg in a recent bestselling book called the “The Power of Habit.” Duhigg points out that habits make up 40 percent of our daily routine, and they all start with a psychological

    more...
  • Most pharmacies refer to medication synchronization as the organization of a person’s medications so that they can be filled on the same day each month. The process in which a person’s medications are synchronized varies by pharmacy organization performing the synchronization.  The most popular synchronization system has been the appointment-based system.  There are challenges with scaling this system with only a few individual companies offering a more automated model.

    more...
  • Medication non-adherence is a complex medical problem, and represents a significant business challenge. For pharmaceutical companies alone, global non-adherence represents revenue losses of $564 billion a year.1 As a result, pharmaceutical companies, retail pharmacies and insurers are increasing their investment in adherence programs. Program spending increased by 281% in 2012, with average budgets reaching $1.5 million.2

    more...
  • For people taking multiple medications, frequent trips to the pharmacy to pick up prescriptions can be a huge hassle.

    more...
  • Changes in the payment methodology for health plans with Medicare Advantage contracts are driving a renewed focus on patient medication adherence and related innovations. These changes are commonly referred to as the reason for the shift toward “pay for performance” in the U.S. healthcare industry.

    more...
  • Adherence to medications is essential for realizing their benefits; however, almost half of patients prescribed medications for chronic diseases omit many doses and/or completely discontinue dosing. Improving medication adherence is complex because there is no single fix and the successful management of patient adherence requires the support of healthcare systems, providers, patients and their social networks.[i]

    more...